Clinical Trial Update: Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update on LEP-ETU, a liposome-entrapped paclitaxel formulation, in patients with advanced cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• LEP-ETU (liposome-entrapped paclitaxel)

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Neoplasm | Phase 1 | Status: COMPLETED